Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add filters








Year range
1.
Clinics ; 72(10): 637-641, Oct. 2017. tab, graf
Article in English | LILACS | ID: biblio-890682

ABSTRACT

Uterine leiomyoma is the most frequently occurring solid pelvic tumor in women during the reproductive period. Magnetic resonance-guided high-intensity focused ultrasound is a promising technique for decreasing menorrhagia and dysmenorrhea in symptomatic women. The aim of this study is to review the role of Magnetic resonance-guided high-intensity focused ultrasound in the treatment of uterine fibroids in symptomatic patients. We performed a review of the MEDLINE and Cochrane databases up to April 2016. The analysis and data collection were performed using the following keywords: Leiomyoma, High-Intensity Focused Ultrasound Ablation, Ultrasonography, Magnetic Resonance Imaging, Menorrhagia. Two reviewers independently performed a quality assessment; when there was a disagreement, a third reviewer was consulted. Nineteen studies of Magnetic resonance-guided high-intensity focused ultrasound-treated fibroid patients were selected. The data indicated that tumor size was reduced and that symptoms were improved after treatment. There were few adverse effects, and they were not severe. Some studies have reported that in some cases, additional sessions of Magnetic resonance-guided high-intensity focused ultrasound or other interventions, such as myomectomy, uterine artery embolization or even hysterectomy, were necessary. This review suggests that Magnetic resonance-guided high-intensity focused ultrasound is a safe and effective technique. However, additional evidence from future studies will be required before the technique can be recommended as an alternative treatment for fibroids.


Subject(s)
Humans , Female , High-Intensity Focused Ultrasound Ablation/methods , Leiomyoma/surgery , Magnetic Resonance Imaging, Interventional/methods , Uterine Neoplasms/surgery , Hysterectomy/methods , Leiomyoma/diagnostic imaging , Leiomyoma/pathology , Quality of Life , Treatment Outcome , Tumor Burden , Uterine Neoplasms/diagnostic imaging , Uterine Neoplasms/pathology
2.
Yonsei Medical Journal ; : 565-571, 2016.
Article in English | WPRIM | ID: wpr-52545

ABSTRACT

PURPOSE: To compare prostate cancer detection rates between 12 cores transrectal ultrasound-guided prostate biopsy (TRUS-Bx) and visually estimated multiparametric magnetic resonance imaging (mp-MRI)-targeted prostate biopsy (MRI-visual-Bx) for patients with prostate specific antigen (PSA) level less than 10 ng/mL. MATERIALS AND METHODS: In total, 76 patients with PSA levels below 10 ng/mL underwent 3.0 Tesla mp-MRI and TRUS-Bx prospectively in 2014. In patients with abnormal lesions on mp-MRI, we performed additional MRI-visual-Bx. We compared pathologic results, including the rate of clinically significant prostate cancer cores (cancer length greater than 5 mm and/or any Gleason grade greater than 3 in the biopsy core). RESULTS: The mean PSA was 6.43 ng/mL. In total, 48 of 76 (63.2%) patients had abnormal lesions on mp-MRI, and 116 targeted biopsy cores, an average of 2.42 per patient, were taken. The overall detection rates of prostate cancer using TRUS-Bx and MRI-visual-Bx were 26/76 (34.2%) and 23/48 (47.9%), respectively. In comparing the pathologic results of TRUS-Bx and MRI-visual-Bx cores, the positive rates were 8.4% (77 of 912 cores) and 46.6% (54 of 116 cores), respectively (p<0.001). Mean cancer core lengths and mean cancer core percentages were 3.2 mm and 24.5%, respectively, in TRUS-Bx and 6.3 mm and 45.4% in MRI-visual-Bx (p<0.001). In addition, Gleason score ≥7 was noted more frequently using MRI-visual-Bx (p=0.028). The detection rate of clinically significant prostate cancer was 27/77 (35.1%) and 40/54 (74.1%) for TRUS-Bx and MRI-visual-Bx, respectively (p<0.001). CONCLUSION: MRI-visual-Bx showed better performance in the detection of clinically significant prostate cancer, compared to TRUS-Bx among patients with a PSA level less than 10 ng/mL.


Subject(s)
Adenocarcinoma/blood , Aged , Biopsy/methods , Endoscopic Ultrasound-Guided Fine Needle Aspiration/methods , Humans , Magnetic Resonance Imaging/methods , Magnetic Resonance Imaging, Interventional/methods , Male , Middle Aged , Neoplasm Grading , Prostate/diagnostic imaging , Prostate-Specific Antigen/blood , Prostatic Neoplasms/blood , Ultrasonography, Interventional/methods
3.
Yonsei Medical Journal ; : 503-509, 2015.
Article in English | WPRIM | ID: wpr-141613

ABSTRACT

PURPOSE: We evaluated the safety and effectiveness of the Magnetic Resonance-guided Focused Ultrasound (MRgFUS) with the ExAblate Conformal Bone System for the palliation of painful bone metastases. MATERIALS AND METHODS: Our Institutional Review Board approved this study, and all patients gave informed consent prior to enrollment. A total of six painful metastatic bone lesions in five patients were treated using MRgFUS with the ExAblate Conformal Bone System for pain palliation. The follow-up sessions were at 3 days, 2 weeks, 1, 2, and 3 months, and 1 year after treatment. Efficacy was evaluated by the changes in visual analog scale (VAS) scores. At 3-months and 1-year follow-ups, unenhanced computed tomography and contrast-enhanced MR imaging examinations were performed. All adverse events were assessed to evaluate treatment safety. RESULTS: All patients showed significant pain relief within 2 weeks. Two patients experienced complete pain reduction that lasted for 1 year. Two other patients showed pain relief measured as VAS scores of 2 and 4 on their last follow-up. Although the remaining patient had experienced significant pain relief in two lesions, the VAS score re-increased on his last follow-up. The size of the enhancing soft tissue mass in metastatic lesions decreased, and new bone formation was seen on follow-up images. Although adverse events were not serious, non-specific leg pain and second degree skin burn were noted. CONCLUSION: MRgFUS was demonstrated to be effective palliative treatment within 2 weeks in selected patients with painful bone metastases.


Subject(s)
Adult , Aged , Bone Neoplasms/secondary , Contrast Media , Female , High-Intensity Focused Ultrasound Ablation/adverse effects , Humans , Magnetic Resonance Imaging, Interventional/methods , Magnetic Resonance Spectroscopy , Male , Middle Aged , Pain , Pain Management , Palliative Care , Prospective Studies , Tomography, X-Ray Computed , Treatment Outcome , Young Adult
4.
Yonsei Medical Journal ; : 503-509, 2015.
Article in English | WPRIM | ID: wpr-141612

ABSTRACT

PURPOSE: We evaluated the safety and effectiveness of the Magnetic Resonance-guided Focused Ultrasound (MRgFUS) with the ExAblate Conformal Bone System for the palliation of painful bone metastases. MATERIALS AND METHODS: Our Institutional Review Board approved this study, and all patients gave informed consent prior to enrollment. A total of six painful metastatic bone lesions in five patients were treated using MRgFUS with the ExAblate Conformal Bone System for pain palliation. The follow-up sessions were at 3 days, 2 weeks, 1, 2, and 3 months, and 1 year after treatment. Efficacy was evaluated by the changes in visual analog scale (VAS) scores. At 3-months and 1-year follow-ups, unenhanced computed tomography and contrast-enhanced MR imaging examinations were performed. All adverse events were assessed to evaluate treatment safety. RESULTS: All patients showed significant pain relief within 2 weeks. Two patients experienced complete pain reduction that lasted for 1 year. Two other patients showed pain relief measured as VAS scores of 2 and 4 on their last follow-up. Although the remaining patient had experienced significant pain relief in two lesions, the VAS score re-increased on his last follow-up. The size of the enhancing soft tissue mass in metastatic lesions decreased, and new bone formation was seen on follow-up images. Although adverse events were not serious, non-specific leg pain and second degree skin burn were noted. CONCLUSION: MRgFUS was demonstrated to be effective palliative treatment within 2 weeks in selected patients with painful bone metastases.


Subject(s)
Adult , Aged , Bone Neoplasms/secondary , Contrast Media , Female , High-Intensity Focused Ultrasound Ablation/adverse effects , Humans , Magnetic Resonance Imaging, Interventional/methods , Magnetic Resonance Spectroscopy , Male , Middle Aged , Pain , Pain Management , Palliative Care , Prospective Studies , Tomography, X-Ray Computed , Treatment Outcome , Young Adult
6.
Article in English | WPRIM | ID: wpr-15372

ABSTRACT

OBJECTIVE: To report the feasibility of magnetic resonance imaging (MRI)-guided intervention for diagnosing suspicious breast lesions detectable by MRI only, using the freehand technique with a 3.0-T closed-bore MRI scanner. MATERIALS AND METHODS: Five women with 5 consecutive MRI-only breast lesions underwent MRI-guided intervention: 3 underwent MRI-guided needle localization and 2, MRI-guided vacuum-assisted biopsy. The interventions were performed in a 3.0-T closed-bore MRI system using a dedicated phased-array breast coil with the patients in the prone position; the freehand technique was used. Technical success and histopathologic outcome were analyzed. RESULTS: MRI showed that four lesions were masses (mean size, 11.5 mm; range, 7-18 mm); and 1, a nonmass-like enhancement (maximum diameter, 21 mm). The locations of the lesions with respect to the breast with index cancer were as follows: different quadrant, same breast - 3 cases; same quadrant, same breast - 1 case; and contralateral breast - 1 case. Histopathologic evaluation of the lesions treated with needle localization disclosed perilobular hemangioma, fibrocystic change, and fibroadenomatous change. The lesions treated with vacuum-assisted biopsy demonstrated a radial scar and atypical apocrine hyperplasia. Follow-up MRI after 2-7 months (mean, 4.6 months) confirmed complete lesion removal in all cases. CONCLUSION: MRI-guided intervention for breast lesions using the freehand technique with a 3.0-T closed-bore MRI scanner is feasible and accurate for diagnosing MRI-only lesions.


Subject(s)
Adult , Biopsy, Needle , Breast Neoplasms/pathology , Contrast Media , Diagnosis, Differential , Feasibility Studies , Female , Gadolinium DTPA , Humans , Magnetic Resonance Imaging/instrumentation , Magnetic Resonance Imaging, Interventional/methods , Middle Aged , Neoplasm Staging , Retrospective Studies , Vacuum
7.
Article in English | WPRIM | ID: wpr-228971

ABSTRACT

OBJECTIVE: To evaluate the effectiveness of uterine artery embolization (UAE) for treating symptomatic fibroids with high signal intensity (SI) on magnetic resonance (MR) T2-weighted imaging (T2WI). MATERIALS AND METHODS: A total of 537 cases, consisting of 14 patients with high SI fibroids on T2WI (T2 high group), were retrospectively included and compared with 28 randomly selected patients with low SI fibroids on T2WI (control group). High SI of a predominant fibroid on T2WI was defined as having the same or higher SI than the myometrium. Patient ages ranged from 28 to 52 years (mean, 38.1 years). All patients underwent MRI before and after UAE. Predominant fibroid and uterine volumes were calculated with MR images. Symptom status in terms of menorrhagia and dysmenorrhea was scored on a scale of 0-10, with 0 being no symptoms and 10 being the baseline, or initial symptoms. RESULTS: Of the patients in the T2 high group, 13 out of 14 (92.9%) patients demonstrated complete necrosis of the predominant fibroids. The mean volume reduction rates of the predominant fibroids in the T2 high group was 61.7% at three months after UAE, which was significantly higher than the volume reduction rates of 42.1% noted in the control group (p < 0.05). Changes in symptom scores for menorrhagia and dysmenorrhea after UAE (baseline score minus follow-up score) were 4.9 and 7.5 in T2 high group and they were 5.0 and 7.7 in control group, suggesting a significant resolution of symptoms (p < 0.01) in both groups but no significant difference between the two groups. CONCLUSION: UAE is effective for uttering fibroids showing high SI on T2WI. The mean volume reduction rate of the predominant fibroids three months after UAE was greater in the T2 high group than in the control group.


Subject(s)
Adult , Case-Control Studies , Contrast Media , Female , Humans , Leiomyoma/therapy , Magnetic Resonance Imaging, Interventional/methods , Meglumine , Middle Aged , Organometallic Compounds , Surveys and Questionnaires , Retrospective Studies , Treatment Outcome , Uterine Artery Embolization/methods , Uterine Neoplasms/therapy
8.
Yonsei Medical Journal ; : 451-453, 2010.
Article in English | WPRIM | ID: wpr-40395

ABSTRACT

This report discusses a pregnancy case following a series of two consecutive magnetic resonance imaging-guided focused ultrasound surgery (MRgFUS) procedures for the treatment of two different myomas in an individual patient. Both procedures were completed without adverse events, and the patient conceived naturally four months after treatment. At 39 weeks, she gave birth to a healthy baby girl, via a vaginal delivery. There were no complications in the pregnancy or during labor.


Subject(s)
Adult , Female , Humans , Magnetic Resonance Imaging, Interventional/methods , Myoma/surgery , Pregnancy , Pregnancy Outcome , Surgery, Computer-Assisted/methods , Uterine Neoplasms/surgery
9.
Radiol. bras ; 41(5): 343-348, set.-out. 2008. ilus
Article in English, Portuguese | LILACS | ID: lil-496940

ABSTRACT

Os procedimentos percutâneos orientados por imagem têm ganhado espaço crescente na radiologia intervencionista, constituindo ferramenta eficaz para a abordagem diagnóstica e terapêutica de massas e coleções nos diversos segmentos corporais. No entanto, localizações pélvicas profundas ainda representam grande desafio para o radiologista, por causa da interposição de estruturas anatômicas. Para que o procedimento seja bem sucedido é fundamental o planejamento da via de acesso baseado no conhecimento detalhado da anatomia radiológica da pelve. As principais vias de acesso para a abordagem destas lesões são: transabdominais (anterior e lateral), extraperitoneal ântero-lateral, transvaginal, transretal e transglútea. O objetivo deste trabalho é fazer uma revisão da anatomia seccional pélvica normal, demonstrando as diversas vias de acesso para biópsias e drenagens guiadas pela ultra-sonografia e pela tomografia computadorizada, bem como discutir as principais vantagens e complicações potenciais de cada uma delas.


Image-guided percutaneous procedures have increasingly been established as safe and effective interventional tools in the diagnosis and management of masses and collections in several body segments. However, lesions in deep pelvic sites still pose a challenge for radiologists because of overlying anatomic structures. The success of a percutaneous biopsy depends on a safe access route planning based on a deep understanding of cross sectional anatomy of the pelvis. Anterior and lateral transabdominal, anterolateral extraperitoneal, transvaginal, transrectal and transgluteal approaches are described. The present study was aimed at reviewing the normal pelvic cross-sectional anatomy, demonstrating the different access routes for ultrasonography and computed tomography guided pelvic biopsies and drainages as well as discussing the main advantages and complications associated with these approaches.


Subject(s)
Humans , Drainage , Pelvis/anatomy & histology , Pelvis/physiology , Pelvis , Biopsy , Magnetic Resonance Imaging, Interventional/methods , Radiology, Interventional
SELECTION OF CITATIONS
SEARCH DETAIL